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Background: Porcine reproductive and respiratory syndrome virus (PRRSV) infection leads to substantial economic
losses to the swine industry worldwide. However, no effective countermeasures exist to combat this virus infection
so far. The most common antiviral strategy relies on directly inhibiting viral proteins. However, this strategy
invariably leads to the emergence of drug resistance due to the error-prone nature of viral ploymerase. Targeting
cellular proteins required for viral infection for developing new generation of antivirals is gaining concern. Recently,
heat shock protein 90 (HSP90) was found to be an important host factor for the replication of multiple viruses and
the inhibition of HSP90 showed significant antiviral effects. It is thought that the inhibition of HSP90 could be
a promising broad-range antiviral approach. However, the effects of HSP90 inhibition on PRRSV infection have
not been evaluated. In the current research, we tried to inhibit HSP90 and test whether the inhibition affect
PRRSV infection.
Methods: We inhibit the function of HSP90 with two inhibitors, geldanamycin (GA) and 17- allylamono-
demethoxygeldanamycin (17-AAG), and down-regulated the expression of endogenous HSP90 with specific
small-interfering RNAs (siRNAs). Cell viability was measured with alamarBlue. The protein level of viral N was
determined by western blotting and indirect immunofluorescence (IFA). Besides, IFA was employed to examine
the level of viral double-stranded RNA (dsRNA). The viral RNA copy number and the level of IFN-β mRNA were
determined by quantitative real-time PCR (qRT-PCR).
Results: Our results indicated that both HSP90 inhibitors showed strong anti-PRRSV activity. They could reduce viral
production by preventing the viral RNA synthesis. These inhibitory effects were not due to the activation of innate
interferon response. In addition, we observed that individual knockdown targeting HSP90α or HSP90β did not show
dramatic inhibitory effect. Combined knockdown of these two isoforms was required to reduce viral infection.
Conclusions: Our results shed light on the possibility of developing potential therapeutics targeting HSP90 against
PRRSV infection.
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Porcine reproductive and respiratory syndrome (PRRS)
is characterized by severe reproductive failure in sows,
and respiratory disease in young piglets, and causes
huge economic losses in the swine industry [1]. The etio-
logic agent, porcine reproductive and respiratory syn-
drome virus (PRRSV) is an enveloped, single-stranded
positive-sense RNA virus belonging to the Arteriviridae
family [2] which includes equine arteritis virus (EAV),
lactate dehydrogenase-elevating virus (LDV), and sim-
ian hemorrhagic fever virus (SHFV). Together with the
Coronaviridae and Roniviridae families, Arteriviridae
enters in the newly established order of the Nidovirales
[3]. The genome of PRRSV is approximately 15 kb in
length and encodes nine partially overlapping open reading
frames (ORFs) designated ORF 1a, ORF 1b, and ORFs 2 to
7 [4]. As known, developments of vaccines and therapeu-
tics are vital to the disease control. However, there are still
no effective countermeasures available to treat this deadly
viral disease. Development of effective antiviral strategies
againt PRRSV infection is an urgent need [5,6].
Exposure of cells and tissues to extreme conditions
such as heat, oxidative stress, heavy metals, UV irradi-
ation and microbial/viral infection leads to selective
transcription and translation of heat shock proteins
(HSPs) [7,8]. HSPs are highly conserved and ubiquitous
cytoprotective proteins, and involved in a multitude of
cellular processes, including protein folding, refolding
of stress-denatured protein, protein trafficking and deg-
radation [9-11]. Based on their molecular weight, HSPs
are divided into different classes: HSP100, HSP90,
HSP70, HSP60, HSP40 and small HSPs [12]. HSP90 is
one of highly abundant, essential, and conserved mo-
lecular chaperones present in eukaryotes [13]. Recently,
HSP90 was shown to be an essential host factor for viral
infection. It can be involved in different stages of the
viral life cycle, including translocation [14,15], replica-
tion [12-14], gene expression [16], and virion morpho-
genesis [17]. Inhibition of HSP90 has been shown to
reduce the replication of multiple viruses, such as vac-
cinia virus [18], hepatitis C virus [19], ebola virus [20],
influenza virus [15], rotavirus [21], human cytomegalo-
virus [22], herpes simplex virus type 1 [23] and infec-
tious bursal disease virus [24]. Accordingly, inhibition
of HSP90 was regarded as a broad-range antiviral strat-
egy [25]. However, the effects of HSP90 inhibition on
PRRSV infection have not been evaluated. In current re-
search, we inhibited HSP90 using specific functional in-
hibitors or RNA interference and evaluated the effects
on PRRSV infection in vitro.
We found that the functional inhibition of HSP90
with two inhibitors, GA and 17-AAG, significantly re-
duced viral RNA synthesis, and attenuated final produc-
tion. The addition of GA or 17-AAG did not induce theexpression of IFN-β, indicating that these inhibitory
effects are not due to the activation of innate interferon
response.
Interestingly, no significant inhibitory effect was observed
when individual knockdown of HSP90α or HSP90β. Com-
bined knockdown of these two isoforms shown dramatic
antiviral effect, suggesting that these two isoforms might
have overlapping functions during PRRSV replication.
Results
The Cytotoxic Effects of HSP90 Inhibitors
The cytotoxic effects of two HSP90 inhibitors (GA and
17-AAG) on two types of PRRSV permissive cells,
MARC-145 cells (Figure 1A) and primary porcine
alveolar macrophages (PAMs) (Figure 1B), were exam-
ined by the alamarBlue cell viability assay (see Materials
and methods). No significant toxicity was observed at
concentrations of both inhibitors below 5 μM in MARC-
145 cells (Figure 1A). PAMs were shown more sensitive to
GA or 17-AAG and the minimal toxicity was found at
concentrations below 2 μM (Figure 1B). Therefore, we
performed future experiments with these two inhibitors at
concentrations no higher than 5 μM in MARC-145 cells,
and no higher than 2 μM in PAMs.
HSP90 inhibitors attenuate the production of viral
progeny
To tested the effects of two HSP90 inhibitors on the
PRRSV production. PRRSV-infected MARC-145 cells or
PAMs were treated with different concentrations of in-
hibitors. Viral titers were measured at 24 hous post in-
fection (h.p.i). We observed that both HSP90 inhibitors
reduced the production of PRRSV progeny in two cell
types (Figure 2), and the inhibitory effects were found in
a does-dependent manner (Figure 2A).
HSP90 inhibitors decrease the viral protein level
We also evaluated the effects of the inhibitors on viral
protein level. The expression of viral N protein in GA-
or 17-AAG-treated cells was detected by western blot-
ting and IFA. Similar inhibitory effects were found in
viral protein level (Figure 3). GA or 17-AAG could de-
crease the level of viral N protein in a does-dependent
manner (Figure 3A and 3C).
GA or 17-AAG prevent the viral RNA synthesis
To investigate whether these inhibitory effects is due to
the blockade of viral RNA synthesis, we performed
strand-specific qRT-PCR [26] to measure the levels of
PRRSV full-length minus-strand RNA. Our results showed
that inhibitors treatment at the concentration of 2 μM
could reduce the level of viral full-length minus-strand
RNA in two cell types, dramatically (Figure 4A and 4B).
Figure 1 The cell toxicity of GA and 17-AAG. (A) MARC-145 cells and (B) PAMs were seeded in 96-well plates and then treated with serial
concentration of drugs for 24 hours. Cell viability was measured using alamarBlue. Data are mean ± SD, n = 3, and significant differences
compared with control are denoted by *(P < 0.05).
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virus replication or transcription. The visualization of
viral dsRNA has been shown to be a convenient ap-
proach to monitor the RNA synthesis of positive-sense
RNA virus [27,28]. Therefore, IFA was performed to de-
tect the level of viral dsRNA in inhibitors-treated MARC-
145 cells. PRRSV dsRNA was shown mostly accumulating
in the perinuclear region as observed in other positive-
strand RNA viruses-infected cells. The amount of dsRNA
was reduced in a dose-dependent manner in the presence
of chemicals (Figure 4C).Figure 2 HSP90 inhibitors reduced PRRSV production. (A) MARC-145 cel
of drugs. The culture supernatants were collected at 24 h.p.i and viral titers w
significant differences compared with DMSO (in MARC-145 cells) or no drug (Interferon response is not triggered by HSP90 inhibitors
The activation of type I interferon pathway is important
for host against viral infection. To investigate whether
GA- or 17-AAG-mediated inhibitory effects on PRRSV
infection are due to the activation of interferon response,
qRT-PCR was performed to measure the IFN-β mRNA
level in inhibitors-treated cells. The IFN-β expression
was not induced after inhibitors treatment in two cell
types. As positive control, lipopolysaccharide (LPS) treat-
ment could significantly elevate the level of IFN-β gene
transcription (Figure 5).ls and (B) PAMs were infected and treated with different concentrations
ere determined by calculating CCID50. Data are mean ± SD, n = 3, and
in PAMs) treatment group, respectively, are denoted by *(P < 0.05).
Figure 3 GA and 17-AAG decreased the level of viral N protein. PRRSV-infected cells were treated with chemicals at the concentration as
indicated. Mock-infected cells were untreated. (A) MARC-145 cells and (B) PAMs were harvested at 24 h.p.i for western blotting analysis. The level
of viral N protein was quantified by measuring band intensities and normalized with respect to the amount of β-actin. Data are mean ± SD, n = 3,
and significant differences compared with DMSO (in MARC-145 cells) or no drug (in PAMs) treatment group, respectively, are denoted by
*(P < 0.05). (C) Inhibitors-treated MARC-145 cells were fixed at 24 h.p.i to detect viral N protein (red) by IFA. Nuclei were stained with Hoechst
dye 33258 (blue). Bar, 200 μm.
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to reduce the viral infection
The effects of knockdown of HSP90 on viral infection
were also tested. In mammalian cells, there are two
HSP90 isoforms, HSP90α and HSP90β, encoded by sep-
arate genes, and are essential for a multitude of cellular
processes [29]. Therefore, we transfected siRNAs target-
ing each isoform or both into MARC-145 cells. Western
blotting analysis showed that HSP90α and Hsp90β were
down-regulated by siRNA, specifically (Figure 6A, lanes
3 and 4). Combined knockdown led to a dramatic reduc-
tion of viral N protein level and viral yields (Figure 6A,
lanes 5; 6B). Interestingly, no significant antiviral effectswere found when individual knockdown (Figure 6A, lanes
3 and 4; 6B). It may be due to the fact that individual
knockdown could not lead to sufficient reduction of the
total HSP90 (Figure 6A, lanes 3 and 4).
Discussion
Infection with PRRSV causes a high mortality and leads to
substantial economic losses to the swine industry world-
wide. Vaccines have been developed to control PRRSV in-
fection, but failed to provide sustainable disease control
because of the viral immune evasion strategies and the
antigenic heterogeneity of field strains [30]. Hence, the de-
velopment effective antiviral strategies to combat PRRSV
Figure 4 HSP90 inhibitors prevented the viral RNA synthesis. PRRSV-infected cells were treated with chemicals at the concentration as
indicated. Mock-infected cells were untreated. (A) MARC-145 cells and (B) PAMs were harvested at 24 h.p.i. Total RNA was isolated and
strand-specific qRT-PCR was performed to determine the viral full-length minus-stranded RNA copy number. Data are mean ± SD, n = 3, and
significant differences compared with DMSO (in MARC-145 cells) or no drug (in PAMs) treatment group, respectively, are denoted by *(P < 0.05).
(C) Inhibitors-treated MARC-145 cells were fixed at 24 h.p.i to detect viral dsRNA (red) by IFA. Nuclei were stained with Hoechst dye 33258 (blue).
Bar, 50 μm.
Figure 5 GA or 17-AAG did not induce the IFN-β gene transcription. (A) MARC-145 cells or (B) PAMs were treated with different concentrations
of drugs for 10 hours and total cellular RNA was extracted for qRT-PCR analysis of IFN-β gene transcription.
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Figure 6 The effects of knockdown of HSP90 on PRRSV infection. (A) MARC-145 cells were transfected with different concentrations of
siRNAs for 24 hours and subsequently infected with PRRSV. Cells were harvested at 24 h.p.i for western blotting analysis. The relative protein
level of viral N was quantified by measuring band intensities and normalized with respect to the amount of β-actin. Meanwhile, (B) the culture
supernatants were collected and viral titers were determined by calculating CCID50. Data are mean ± SD, n = 3, and significant differences
compared with control are denoted by *(P < 0.05).
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viral strategy relies on directly inhibiting viral proteins.
However, this strategy invariably results in the emergence
of drug resistance, as the virus can readily mutate to cir-
cumvent inhibition due to the error-prone nature of the
ploymerase, even under conditions of combinatorial ther-
apy targeting multiple viral proteins [31]. Targeting cellu-
lar proteins for developing new generation of antivirals is
gaining concern [19-21,32]. HSP90 inhibitors, such as her-
bimycin A, radicicol, GA and its derivatives, characterized
as effective anti-cancer therapeutics and several of which
now in phase I and II clinical trials [33,34], have been
shown to have strong antiviral activity. Strikingly, in the
case of poliovirus, GA treatment did not led to the
emergence of drug resistance within 10 passages [32].Therefore, it is thought that HSP90 inhibitors could be
promising broad-range antiviral agents. We have previ-
ously shown that HSP90 was elevated in PRRSV infected
lungs relative to uninfected negative control (UNC) lungs
based on transcriptome and proteome approaches [35,36],
suggesting that HSP90 might be an important host factor
for PRRSV infection as observed for other viruses. There-
fore, we tried to inhibit HSP90 and test whether the inhib-
ition could affect PRRSV infection.
In the present study, we found both inhibitors could
block the synthesis of PRRSV RNA, and thus reduce
viral infection in vitro. PAMs are known to be the pri-
mary host cellular target for PRRSV replication, thus the
significant antiviral effects of these agents in these cells
suggests that they might also be effective inhibitors
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Notably, GA or 17-AAG treatment could not induce
IFN-β gene expression in both cell types. A previous re-
search has showed that GA can inhibit the dsRNA- or
virus-induced IFN-β gene expression in HeLa cells [37].
These results suggest that the anti-PRRSV activities per-
formed by HSP90 inhibitors are not due to the activation
of interferon response.
We also evaluated the effects of siRNA-mediated knock-
down of HSP90 on PRRSV infection. The simultaneous
depletion of both proteins led to a dramatic reduction of
viral infection. However, no significant inhibitory effects
were observed when individual knockdown, suggesting
that these two isoforms might have overlapping functions
during PRRSV infection. Interestingly, HSP90α was up-
regulated after transfection with siRNA targeting HSP90β
(Figure, 6A, lane 4), which is consistent with a previous
research [38], indicating a compensatory up-regulation.
But the corresponding augmentation of HSP90β after
transfection of siHSP90α was not observed (Figure, 6A,
lane 3), which may be due to the fact that HSP90β is
generally constitutive and not sensitive to a great variety
of stimuli [29,39].
As known, HSP90 can be involved in different stages of
the viral life cycle. Our results showed that the PRRSV
RNA synthesis was prevented by GA and 17-AAG treat-
ment, suggesting that HSP90 is somehow involved in sup-
porting the PRRSV replication. In addition, lower levels of
viral protein and viral production were found. Hence, it is
not excluded that HSP90 may also be involved in the
PRRSV life cycle at the steps of protein synthesis and
budding. Notably, the inhibitory effects observed in this
study are not due to inhibition in virus adsorption or
entry since in all exprements, the inhibitors were added
at 1 h.p.i, when PRRSV has been internalized in host
cells [40]. The addition of inhibitors, even at 4 h.p.i, also
showed significant inhibitory effects (data not shown).
However, these results could not exclude the possibility
that HSP90 could regulate PRRSV infection in absorp-
tion and internalization.
The exact roles that HSP90 plays during PRRSV infec-
tion remain to be determined. HSP90 can regulate viral
infection by modulating the host processes or interacting
with viral proteins directly [21,25]. Therefore, further
study will be mainly performed in our laboratory in two
aspects: (I) identification of PRRSV protein associated
with HSP90 directly; (II) investigation whether HSP90
is exploited by PRRSV to regulate cellular processes for
its benefit.
Conclusions
Our results provide some insight into possible future
development of potential therapeutics against PRRSV
infection.Methods
Cell culture
MARC-145 cultured in Dulbecco’s modified Eagle’s
medium (DMEM) containing 10% Fetal Bovine Serum
(FBS) were maintained at 37°C with 5% CO2.
PAMs were obtained postmortem lung lavage of
8-week-old specific pathogen free (SPF) pigs, and main-
tained in RPMI 1640 medium containing 10% FBS and
penicillin/streptomycin.
Chemicals and antibodies
GA and 17-AAG obtained from Invivogen (San Diego,
CA, USA) were re-suspended in DMSO.
Rabbit anti-actin, anti-HSP90α, anti-HSP90β, anti-
HSP90 antibodies were obtained from Cell Signaling
Technology (Beverly, MA, USA). Mouse anti-PRRSV N
protein antibody was obtained from Jeno Biotech Inc
(Chuncheon, South Korea). Mouse monoclonal antibody
specific for dsRNA (J2) was purchased from Scicons
(Hungary).
Virus infection and chemicals treatment
Cells were infected with PRRSV strain CH-1a (the first
type 2 PRRSV strain isolated in China, kindly provided
by Dr. Guihong Zhang in South China Agricultural
University, China) at an MOI of 0.1. At 1 h.p.i, cells
were untreated (no drug) or treated with GA, 17-AAG,
or DMSO. The 50% cell culture infection dose (CCID50)
was calculated at 24 h.p.i by the Reed-Muench method.
Cells were treated with different concentrations of
drugs or LPS (at the final concentration of 10 μg/ml, as
positive control) for 10 hours and harvested for IFN-β
transcription analysis.
Cell viability assay
Cells were seeded into 96-well plates. After 24 hours
treatment with GA or 17-AAG, cells were incubated at
37°C with fresh DMEM medium containing 10% alamar-
Blue (Invitrogen, Carlsbad, CA, USA) for 4 hours in ac-
cordance with the manufacturer’s protocol. Fluorescence
was monitored at 570 nm excitation and 590 nm emission
wavelengths using a Synergy 2 Multi-Mode Microplate
reader (BioTek). The fluorescence was directly propor-
tional to the number of living cells in culture.
SiRNAs and transfection
SiRNAs were obtained from Ribobio (Guangzhou, China),
and used at a 50 nM final concentration. MARC-145 cells
grown to approximately 30-50% confluence in 6-well
plates were transfected with no siRNA (control), scramble
siRNA, siHSP90α (50 nM), siHSP90β (50 nM), or both
siHSP90α (25 nM) and siHSP90β (25 nM) using lipofecta-
mine 2000 (Invitrogen) according to the manufacturer’s
instruction.
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Cells were harvested and total RNA was isolated at 24 h.
p.i with TRIzol™ reagent (Invitrogen) according to the
manufacturer’s instruction. The synthesis of the first
strand of cDNA was performed using a reverse tran-
scription kit (Promega, Madison, WI, USA). Quantitative
PCR was performed with SYBR Premier Dimer Eraser™
kit (TaKaRa, China) using LightCycler® 480 Real-Time
PCR System and analyzed with LightCycler® 480 soft-
ware (Roche). The detection of full-length minus-strand
RNA was performed as described in previous study [26].
Specific primers used for amplification of IFN-β in
MARC-145 cells (mIFN-β) [41] or in PAMs (pIFN-β)




TCTG-3′. The mRNA of GAPDH or HPRT1 served as
internal reference.
Western blotting
Cell pellets were lysed in cell lysis buffer (Beyotime
Biotechnol, Shanghai, China) containing 1 mM phenyl
methyl-sulfonylfluoride (PMSF) and samples were boiled
for 5 minutes. About 25 μg of protein was separated by
sodium dodecyl sulfate- polyacrylamide gel electrophor-
esis (SDS-PAGE) and blotted onto a polyvinyl difluoride
(PVDF) membrane. After blotting, the membrane was
blocked with 5% nonfat dry milk in Tris-Buffered Saline
containing Tween 20 (TBST) for 2 hours and incubated
overnight at 4°C with primary antibody. The membrane
were then washed in TBST and incubated for 1 hour
with the HRP-conjugated secondary antibodies (CST).
Imaging of the blot was performed with super signal
west pico chemiluminescence substrate (Pierce, IL, USA)
using Image Station 4000 mm PRO System (Kodak).
Protein band intensities were measured by Image Station
4000 mm PRO software. The control group was set as 100
to allow comparisons.
Indirect immunofluorescence assay
MARC-145 cells grown on glass slides were fixed with
4% paraformaldehyde in phosphate-buffered saline (PBS)
at room temperature for 10 minutes. After being washed
three times with PBS, the cells were permeabilized for
15 minutes at room temperature with PBS containing
0.5% Triton X-100 and blocked with PBS containing 1%
Bovine serum albumin (BSA) for 30 minutes at room
temperature. The cells were incubated with primary anti-
body in PBS containing 1% BSA at 4°C overnight. The cells
were then washed three times with PBS and incubated with
AF555-conjugated anti-mouse IgG (CST) in PBS contain-
ing 1% BSA at room temperature for 60 minutes. Nuclei
were stained with Hoechst dye 33258 (Sigma-Aldrich, MO,USA) for 4 minutes at room temperature. Finally, the cells
were washed three times with PBS and observed with
ELYRA P.1 prototype system (Carl Zeiss).
Statistical analysis
Data were presented as means ± standard errors and
resulted from three independent experiments. Statis-
tical significance was determined by Student’s t test. A
P value < 0.05 was considered statistically significant.
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